The ocular benefits of estrogen replacement therapy: A population-based study in postmenopausal korean women

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Na, Kyung Sun ^a   Jee, Dong Hyun ^a   Han, Kyungdo ^a   Park, Yong Gyu ^a   Kim, Man Soo ^a   Kim, Eun Chul ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTROGEN; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; CATARACT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ESTROGEN THERAPY; EYE DISEASE; FEMALE; GLAUCOMA; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; KOREAN (PEOPLE); MENOPAUSAL SYNDROME; OPHTHALMOLOGY; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PREVALENCE; PTERYGIUM; RISK ASSESSMENT; SOCIOECONOMICS; AGED; BLOOD; METABOLISM; MIDDLE AGED; SOUTH KOREA;

AGED; CATARACT; DIABETIC RETINOPATHY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GLAUCOMA; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; PTERYGIUM; REPUBLIC OF KOREA;

EID: 84907484029     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106473     Document Type: Article

References (32)

1. Gabriel SR, Carmona L, Roque M, Sánchez GL, Bonfill X (2005) Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 18: CD002229.
2. Tostes RC, Nigro D, Fortes ZB, Carvalho MH (2003) Effects of estrogen on the vascular system. Braz J Med Biol Res 36: 1143-1158.
3. Rosano G, Vitale C, Spoletini I, Fini M (2012) Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy. Climacteric 15: 299-305.
4. Hayashi T, Ina K, Maeda M, Nomura H (2011) The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis. Nitric Oxide 24: 199-203.
5. Maki PM, Henderson VW (2012) Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on. Climacteric 15: 256-262.
6. Craig MC, Murphy DG (2010) Estrogen therapy and Alzheimer's dementia. Ann N Y Acad Sci 1205: 245-253.
7. Tostes RC, Nigro D, Fortes ZB, Carvalho MH (2003) Effects of estrogen on the vascular system. Braz J Med Biol Res 36: 1143-1158.
8. Green PS, Simpkins JW (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18: 347-358.
9. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB (1999) Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 40: 1906-1911.
10. Dahlman-Wright K, Cavadles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, et al. (2006) International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58: 773-781.
11. Gagliano C, Caruso S, Napolitano G, Malaguarnera G, Cicinelli MV, et al. (2014) Low levels of 17-ß-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: a case-control study. Br J Ophthalmol 98: 371-376.
12. Pasquale ER, Loomis SJ, Weinreb RN, Kang JH, Yaspan BL, et al. {2013) Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States. Mol Vis 19: 1471 -1481.
13. Gumming RG, Mitchell P (1997) Hormone replacement therapy, reproductive factors, and cataract. The Blue Mountains Eye Study. Am I Epidemiol 145: 242-249.
14. Klein BE, Klein R, Ritter LL (1994) Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol 112: 85-91.
15. Uncu G, Avci R, Uncu Y, Kaymaz C, Develioglu O (2006) The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol 22: 501-505.
16. Tint NL, Alexander P, Tint KM, Vasileiadis GT, Yeung AM, et al. (2010) Hormone therapy and intraocular pressure in nonglaucomatous eyes. Menopause 17: 157-160.
17. Abramov Y, Borik S, Yahalom C, Fatum M, Avgil G, et al. (2005) Does postmenopausal hormone replacement therapy affect intraocular pressure? J Glaucoma 14: 271-275.
18. Abramov Y, Borik S, Yahalom G, Fatum M, Avgil G, et al. (2004) The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women. Menopause 11: 62-68.
19. Saw SM, Tan D (1999) Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol 6: 219-228.
20. Klein BE, Klein R, Lee KE (2000) Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the beaver dam eye study. Am J Ophthalmol 130: 322-326.
21. Kanthan GE, Wang JJ, Burlutsky G, Rochtchina E, Gumming RG, et al. (2010) Exogenous oestrogen exposure, female reproductive factors and the long-term incidence of cataract: the Blue Mountains Eye Study. Acta Ophthalmol 88: 773 -778.
22. Sator MO, Akramian J, Joura EA, Nessmann A, Wedrich A, et al. (1998) Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 29: 93-95.
23. Sator MO, Joura EA, Frigo P, Kurz C, Metka M, et al. (1997) Hormone replacement therapy and intraocular pressure. Maturitas 28: 55-58.
24. Abramov Y, Borik S, Yahalom C, Fatum M, Avgil G, et al. (2005) Does postmenopausal hormone replacement therapy affect intraocular pressure? J Glaucoma 14: 271-275.
25. Khurana RN, LaBree LD, Scott G, Smith RE, Yiu SC (2006) Esterified estrogens combined with methyltestosterone raise intraocular pressure in postmenopausal women. Am J Ophthalmol 142: 494-495.
26. Deschênes MC, Descovich D, Moreau M, Granger L, Kuchel GA, et al. (2010) Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 51: 2587-2600.
27. Ang M, Li X, Wong W, Zheng Y, Chua D, et al. (2012) Prevalence of and racial differences in pterygium: a multiethnic population study in Asians. Ophthalmology 119: 1509-1515.
28. Li Z, Cui H (2013) Prevalence and associated factors for pterygium in a rural adult population (the Southern Harbin Eye Study). Cornea 32: 806-809.
29. Tan DT, Ghee SP, Dear KB, Lim AS (1997) Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115: 1235-1240.
30. Klein BE, Klein R, Moss SE (1999) Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 22: 1984-1987.
31. Schaumberg DA, Buring JE, Sullivan DA, Dana MR (2001) Hormone replacement therapy and dry eye syndrome. JAMA 286: 2114-2119.
32. Gerhard M. Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 1995 92 5-8.